Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
9.72
-0.04 (-0.41%)
At close: Oct 13, 2025, 4:00 PM EDT
9.90
+0.18 (1.85%)
After-hours: Oct 13, 2025, 7:50 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $747.31 million as of October 13, 2025. Its market cap has decreased by -50.01% in one year.
Market Cap
747.31M
Enterprise Value
374.96M
1-Year Change
-50.01%
Ranking
Category
Stock Price
$9.72
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $747.31M, an increase of 6.14%. That is a compound annual growth rate of 1.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 747.31M | -44.00% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |